TC
MDGL icon

TwinBeech Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

TwinBeech Capital’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,428
Closed -$1.36M – 805
2024
Q3 		$1.36M Buy
+6,428
New +$1.64M 0.03% 462
2023
Q2 		– Sell
-13,016
Closed -$3.15M – 763
2023
Q1 		$3.15M Buy
+13,016
New +$3.55M 0.06% 312
2021
Q3 		– Sell
-2,188
Closed -$213K – 691
2021
Q2 		$213K Buy
+2,188
New +$259K 0.03% 412
2020
Q1 		– Sell
-2,199
Closed -$200K – 402
2019
Q4 		$200K Buy
+2,199
New +$213K 0.06% 360

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return